Introducing TRL
On September 28, 2021, Triall introduced its platform-native utility token TRL. The launch of TRL followed a successful crowdfunding campaign that built a community of over 1,500 investors across the globe.
What's the purpose of TRL?
TRL is a key building block for the envisioned Triall data ecosystem, where it will coordinate fair and equitable exchange of clinical data resources between data providers, data consumers, and service providers.
Network Building
TRL brings together a multi-disciplinary community of 3,000+ TRL holders and 4,400+ members from 50+ countries.
Platform Access
TRL coordinates access to Triall software and services.
Rewards & Incentives
For patient and investigator communities, promoting trial recruitment, retention, and engagement.
Data Monetisation
Enabling fractional data ownership between Sponsor, CROs, Sites, and patients.
Payment & Reimbursement
TRL enables to coordinate milestone-based payments and reimbursements through programmable contracts and workflows.
About the TRL community
The TRL community brings together people from different backgrounds, cultures, and geographies who share a common interest in promoting Triall’s vision for clinical research. Their support as investors and advocates has been and continues to be a key success driver of the Triall ecosystem.
